ArticleNature communications2026

Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer's disease.

Yijun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.